Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “treatment”

2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,520
Index total 30,257
Page 14 / 105

Quick answer

This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,520 results for “treatment” · 30,257 patents in full index Clear search

  1. US 11938124

    Combination therapy for treatment of cancer

    PMV PHARMACEUTICALS, INC. · Granted Mar 26, 2024 · Expires Mar 21, 2044

    granted
  2. US 11938147

    Treatment of neurodegenerative disease with sodium chlorite

    The Regents of the University of California · Granted Mar 26, 2024 · Expires Mar 21, 2044

    granted
  3. US 11938148

    Treatment of neurodegenerative disease with sodium chlorite

    The Regents of the University of California · Granted Mar 26, 2024 · Expires Mar 21, 2044

    granted
  4. US 11938174

    Compositions and methods useful for the treatment of neuromyelitis optica spectrum disorders

    Takeda Pharmaceutical Company Limited · Granted Mar 26, 2024 · Expires Mar 21, 2044

    granted
  5. US 11938150

    Treatment of neurodegenerative disease with sodium chlorite

    The Regents of the University of California · Granted Mar 26, 2024 · Expires Mar 21, 2044

    granted
  6. US 11932852

    Reagents for treatment of oculopharyngeal muscular dystrophy (OPMD) and use thereof

    Benitec IP Holdings Inc. · Granted Mar 19, 2024 · Expires Mar 14, 2044

    granted
  7. US 11931375

    Treatment of amyotrophic lateral sclerosis (ALS)

    VOYAGER THERAPEUTICS, INC. · Granted Mar 19, 2024 · Expires Mar 14, 2044

    granted
  8. US 11931340

    Use of sublingual dexmedetomidine for the treatment of agitation

    BioXcel Therapeutics, Inc. · Granted Mar 19, 2024 · Expires Mar 14, 2044

    granted
  9. US 11931459

    Treatment of pain in pediatric patients by administration of sustained-release liposomal anesthetic compositions

    Pacira Pharmaceuticals, Inc. · Granted Mar 19, 2024 · Expires Mar 14, 2044

    granted
  10. US 11932688

    Treatment for neoplastic diseases

    XBIOTECH INC. · Granted Mar 19, 2024 · Expires Mar 14, 2044

    granted
  11. US 11925675

    Systemic delivery of adeno-associated virus vector expressing gamma-sarcoglycan and the treatment of muscular dystrophy

    Sarepta Therapeutics, Inc. · Granted Mar 12, 2024 · Expires Mar 7, 2044

    granted
  12. US 11926656

    Antibodies and methods for the diagnosis and treatment of Epstein Barr Virus infection

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 12, 2024 · Expires Mar 7, 2044

    granted
  13. US 11926668

    Anti-PD-1 antibodies for treatment of lung cancer

    REGENERON PHARMACEUTICALS, INC. · Granted Mar 12, 2024 · Expires Mar 7, 2044

    granted
  14. US 11925623

    Methods for the treatment of conditions related to hydrogen sulfide

    Regents of the University of Minnesota · Granted Mar 12, 2024 · Expires Mar 7, 2044

    granted
  15. US 11925649

    Treatments for diabetic neuropathy

    The Regents of the University of California · Granted Mar 12, 2024 · Expires Mar 7, 2044

    granted
  16. US 11925629

    Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer

    Asana BioSciences, LLC · Granted Mar 12, 2024 · Expires Mar 7, 2044

    granted
  17. US 11918557

    Treatment of circadian rhythm disorders

    VANDA PHARMACEUTICALS INC. · Granted Mar 5, 2024 · Expires Feb 29, 2044

    granted
  18. US 11918563

    Methods and compositions for treatment of epileptic disorders

    OVID THERAPEUTICS INC. · Granted Mar 5, 2024 · Expires Feb 29, 2044

    granted
  19. US 11918565

    Treatment of post-operative pain via sciatic nerve block with sustained-release liposomal anesthetic compositions

    Pacira Pharmaceuticals, Inc. · Granted Mar 5, 2024 · Expires Feb 29, 2044

    granted
  20. US 11918688

    Treatment of hip pain with sustained-release liposomal anesthetic compositions

    Pacira Pharmaceuticals, Inc. · Granted Mar 5, 2024 · Expires Feb 29, 2044

    granted
  21. US 11918556

    Treatment of circadian rhythm disorders

    VANDA PHARMACEUTICALS INC. · Granted Mar 5, 2024 · Expires Feb 29, 2044

    granted
  22. US 11911385

    Methotrexate treatment methods

    Aldeyra Therapeutics, Inc. · Granted Feb 27, 2024 · Expires Feb 22, 2044

    granted
  23. US 11911368

    Method of treatment of CNS disorders

    Supernus Pharmaceuticals, Inc. · Granted Feb 27, 2024 · Expires Feb 22, 2044

    granted
  24. US 11913027

    Methods of treatment using pluripotent human adipose adult stem cells

    The Regents of the University of California · Granted Feb 27, 2024 · Expires Feb 22, 2044

    granted